Physician and top smoking cessation researcher Dr John Spangler, director of Tobacco Intervention Programs at the Wake Forest University School of Medicine in Winston-Salem, N.C says U.S. regulators and Pfizer brushed aside his concerns a year ago about possibly dangerous side effects from longer-term use of the stop-smoking drug Chantix.
ABC News have the story.
No comments:
Post a Comment